Merck Delivered 900,000 Antiviral Courses to U.S. Last Month

Merck & Co. delivered 900,000 courses of its Covid-19 antiviral pill to the U.S. in December and is set to provide 3 million courses ordered by the government by the end of January, Chief Executive Officer Rob Davis said.

Despite the supply-chain issues that have plagued companies around the world, Davis said Merck was able to make 10 million courses of the drug, molnupiravir, as expected last year. They just need to be labeled and shipped, he said.